Organogenesis Holdings Inc. is indeed a fully public corporate entity whose common stock is traded actively on the NASDAQ stock exchange under the ticker symbol ORGO. As a publicly listed enterprise, it complies with strict regulatory transparency requirements, publishing quarterly financial earnings reports, annual statements, and proxy filings that offer transparent insights into its operating performance and clinical milestones for public market investors.